Literature DB >> 23619436

Polycystic ovarian syndrome.

Nina Madnani1, Kaleem Khan, Phulrenu Chauhan, Girish Parmar.   

Abstract

Polycystic ovarian syndrome (PCOS) is a "multispeciality" disorder suspected in patients with irregular menses and clinical signs of hyperandrogenism such as acne, seborrhoea, hirsutism, irregular menses, infertility, and alopecia. Recently, PCOS has been associated with the metabolic syndrome. Patients may develop obesity, insulin resistance, acanthosis nigricans, Type 2 diabetes, dyslipidemias, hypertension, non-alcoholic liver disease, and obstructive sleep apnoea. Good clinical examination with hematological and radiological investigations is required for clinical evaluation. Management is a combined effort involving a dermatologist, endocrinologist, gynecologist, and nutritionist. Morbidity in addition includes a low "self image" and poor quality of life. Long term medications and lifestyle changes are essential for a successful outcome. This article focuses on understanding the normal and abnormal endocrine functions involved in the pathogenesis of PCOS. Proper diagnosis and management of the patient is discussed.

Entities:  

Mesh:

Year:  2013        PMID: 23619436     DOI: 10.4103/0378-6323.110759

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  4 in total

1.  Prevalence and associated risk factors for mental health problems among patients with polycystic ovary syndrome in Bangladesh: A nationwide cross-Sectional study.

Authors:  Moynul Hasan; Sumaya Sultana; Md Sohan; Shahnaj Parvin; Md Ashrafur Rahman; Md Jamal Hossain; Mohammad Saydur Rahman; Md Rabiul Islam
Journal:  PLoS One       Date:  2022-06-22       Impact factor: 3.752

Review 2.  Female Pattern Hair Loss: a clinical and pathophysiological review.

Authors:  Paulo Müller Ramos; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.896

3.  Inhibition of microRNA-19b promotes ovarian granulosa cell proliferation by targeting IGF-1 in polycystic ovary syndrome.

Authors:  Zhuohui Zhong; Fang Li; Yingying Li; Shuang Qin; Canliang Wen; Yiyuan Fu; Qing Xiao
Journal:  Mol Med Rep       Date:  2018-01-22       Impact factor: 2.952

4.  Polycystic Ovarian Syndrome: Prevalence, Predisposing Factors, and Awareness Among Adolescent and Young Girls of South India.

Authors:  Ayesha Jabeen; Veepuri Yamini; Amtul Rahman Amberina; Mummareddi Dinesh Eshwar; Sabitha Vadakedath; Gulam Saidunnisa Begum; Venkataramana Kandi
Journal:  Cureus       Date:  2022-08-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.